Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0077 | 0.9 |
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.029 | 0.9 |